Kariyazono, Hiroko <br/><br/>
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.  [electronic resource] 

 -  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis  Mar 2004 
 - 157-67 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0957-5235 
<br/><br/><label>Standard No.: </label>10.1097/00001721-200403000-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors<br/>Adenosine Diphosphate--pharmacology<br/>Arachidonic Acid--pharmacology<br/>Aspirin--pharmacology<br/>Carbazoles--pharmacology<br/>Cilostazol<br/>Collagen--pharmacology<br/>Cyclic Nucleotide Phosphodiesterases, Type 3<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Humans<br/>Microscopy, Confocal<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Plasma<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Receptors, Thromboxane A2, Prostaglandin H2--antagonists & inhibitors<br/>Reproducibility of Results<br/>Sulfonamides--pharmacology<br/>Tetrazoles--pharmacology